Suppr超能文献

慢性髓性白血病急变期p190 BCR/ABL转录本与CALR 52-bp缺失共存:一例报告

Coexistence of p190 BCR/ABL Transcript and CALR 52-bp Deletion in Chronic Myeloid Leukemia Blast Crisis: A Case Report.

作者信息

Seghatoleslami Mohammad, Ketabchi Neda, Ordo Alireza, Asl Javad Mohammadi, Golchin Neda, Saki Najmaldin

机构信息

Health Research Institute, Research Center of Thalassemia and Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Department of Medical Genetics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

出版信息

Mediterr J Hematol Infect Dis. 2016 Jan 1;8(1):e2016002. doi: 10.4084/MJHID.2016.002. eCollection 2016.

Abstract

We introduce a 78-year-old woman presented with thrombocytosis and high blast count who had a history of splenectomy. Her cytogenetic analysis revealed aberrant chromosomal rearrangements in different clonal populations harboring 46XX karyotype with t(9;22) (q34;q11). RT-PCR assay detected the e1a2 BCR-ABL translocation resulting from rearrangement of the minor breakpoint cluster region (m-bcr) in BCR gene. Subsequent evaluation of the disease showed calreticulin (CALR) 52-bp deletion as well as the absence of JAK2 (V617F) heterozygous mutation in granulocyte population of peripheral blood using allele-specific PCR and bi-directional DNA sequencing. To our knowledge, this is the first case of a patient initially diagnosed as p190 BCR-ABL transcript positive CML in blast crisis characterized by a 52-bp deletion in CALR gene.

摘要

我们介绍一位78岁女性,有脾切除史,出现血小板增多症和高原始细胞计数。她的细胞遗传学分析显示,具有46XX核型伴t(9;22)(q34;q11)的不同克隆群体中存在异常染色体重排。逆转录聚合酶链反应(RT-PCR)检测发现,BCR基因中微小断点簇区域(m-bcr)重排导致e1a2 BCR-ABL易位。对该疾病的后续评估显示,使用等位基因特异性PCR和双向DNA测序,外周血粒细胞群体中存在钙网蛋白(CALR)52碱基对缺失以及JAK2(V617F)杂合突变缺失。据我们所知,这是首例最初被诊断为p190 BCR-ABL转录本阳性、处于急变期且CALR基因有52碱基对缺失的慢性粒细胞白血病患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c7e/4696471/df80b978cbca/mjhid-8-1-e2016002f1.jpg

相似文献

1
Coexistence of p190 BCR/ABL Transcript and CALR 52-bp Deletion in Chronic Myeloid Leukemia Blast Crisis: A Case Report.
Mediterr J Hematol Infect Dis. 2016 Jan 1;8(1):e2016002. doi: 10.4084/MJHID.2016.002. eCollection 2016.
3
Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations.
J Clin Pathol. 2016 Aug;69(8):713-9. doi: 10.1136/jclinpath-2015-203498. Epub 2016 Jan 11.
7
How to detect the rare BCR-ABL (e14a3) transcript: A case report and literature review.
Oncol Lett. 2017 Nov;14(5):5619-5623. doi: 10.3892/ol.2017.6847. Epub 2017 Aug 28.
10
Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Cancer Genet Cytogenet. 2008 Jan 1;180(1):60-4. doi: 10.1016/j.cancergencyto.2007.09.014.

引用本文的文献

1
Whole-genome sequencing of 490,640 UK Biobank participants.
Nature. 2025 Aug 6. doi: 10.1038/s41586-025-09272-9.
4
Concurrent chronic myeloid leukemia and -mutated myeloproliferative neoplasm.
EXCLI J. 2020 Jan 8;19:86-88. doi: 10.17179/excli2019-2063. eCollection 2020.
5
Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review.
Cancer Res Treat. 2020 Jul;52(3):987-991. doi: 10.4143/crt.2019.703. Epub 2020 Jan 15.
7
Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia.
Hemasphere. 2018 Feb 5;2(1):e29. doi: 10.1097/HS9.0000000000000029. eCollection 2018 Jan-Feb.
8
Buccal epithelial cells display somatic, bone marrow-derived mutation.
Blood Adv. 2017 Nov 16;1(25):2302-2306. doi: 10.1182/bloodadvances.2017012229. eCollection 2017 Nov 28.

本文引用的文献

1
Inhibition of Ras-mediated signaling pathways in CML stem cells.
Cell Oncol (Dordr). 2015 Dec;38(6):407-18. doi: 10.1007/s13402-015-0248-2. Epub 2015 Oct 12.
2
A case of chronic myeloid leukemia with the m-bcr (p190) molecular rearrangement identified during treatment.
Rev Bras Hematol Hemoter. 2015 Jan-Feb;37(1):55-7. doi: 10.1016/j.bjhh.2014.07.024. Epub 2014 Nov 26.
4
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
N Engl J Med. 2013 Dec 19;369(25):2391-2405. doi: 10.1056/NEJMoa1312542. Epub 2013 Dec 10.
5
Somatic mutations of calreticulin in myeloproliferative neoplasms.
N Engl J Med. 2013 Dec 19;369(25):2379-90. doi: 10.1056/NEJMoa1311347. Epub 2013 Dec 10.
6
Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation.
Int J Hematol. 2014 Jan;99(1):87-90. doi: 10.1007/s12185-013-1480-z. Epub 2013 Nov 30.
7
Prognostic factors in chronic myeloid leukaemia.
Best Pract Res Clin Haematol. 2009 Sep;22(3):343-53. doi: 10.1016/j.beha.2009.04.005.
8
Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance.
Blood. 2009 Sep 10;114(11):2232-5. doi: 10.1182/blood-2009-02-204693. Epub 2009 Jun 16.
9
Chronic myeloid leukemia--advances in biology and new approaches to treatment.
N Engl J Med. 2003 Oct 9;349(15):1451-64. doi: 10.1056/NEJMra020777.
10
Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics.
Ann Intern Med. 2003 May 20;138(10):819-30. doi: 10.7326/0003-4819-138-10-200305200-00010.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验